Role of ERK1/2 signaling pathways in 4-aminopyridine-induced rat pulmonary vasoconstriction

Weina Han1, Xiaobo Tang, Hong Wu

  • 1College of Pharmacy, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin, Heilongjiang 150081, P.R. of China.

Insights

Extracellular signal regulated kinase-1/2 (ERK1/2) signaling contributes to pulmonary artery contraction caused by 4-aminopyridione (4-AP). Inhibiting ERK1/2 reduces 4-AP-induced vasoconstriction and phosphorylation of ERK1/2 in pulmonary artery smooth muscle cells.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Biology
  • Pharmacology

Background:

  • Pulmonary vascular tone is regulated by voltage-gated K(+) channels.
  • 4-aminopyridione (4-AP) inhibits these channels, affecting pulmonary artery contraction.
  • The role of extracellular signal regulated kinase-1/2 (ERK1/2) in this process requires elucidation.

Purpose of the Study:

  • To investigate the contribution of the ERK1/2 signaling pathway to pulmonary artery contraction induced by 4-AP.
  • To examine the effect of 4-AP on the expression of phosphorylated ERK1/2 (p-ERK1/2) in pulmonary arterial smooth muscle cells (PASMCs) and tissues.

Main Methods:

  • Isolated rat pulmonary artery rings were used to measure tension changes.
  • ERK1/2 inhibitors (PD98059, U0126) were employed to block ERK1/2 activation.
  • Western blotting was used to assess p-ERK1/2 expression in PASMCs and whole tissues.

Main Results:

  • 4-AP caused a concentration-dependent increase in pulmonary artery ring tension.
  • Pretreatment with ERK1/2 inhibitors PD98059 and U0126 significantly reduced 4-AP-induced vasoconstriction.
  • 4-AP increased p-ERK1/2 expression in PASMCs and tissues, an effect blocked by U0126.

Conclusions:

  • The ERK1/2 signaling pathway plays a significant role in mediating pulmonary vasoconstriction induced by 4-AP.
  • These findings highlight ERK1/2 as a potential target for modulating pulmonary vascular tone.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...